140 related articles for article (PubMed ID: 28847457)
1. Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision.
Allen AA; Chen DT; Bonnie RJ; Ko TM; Suratt CE; Lee JD; Friedmann PD; Gordon M; McDonald R; Murphy SM; Boney TY; Nunes EV; O'Brien CP
J Subst Abuse Treat; 2017 Oct; 81():66-72. PubMed ID: 28847457
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of extended release naltrexone to prevent relapse among criminal justice-involved individuals with a history of opioid use disorder.
Murphy SM; Polsky D; Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Bonnie RJ; Gordon M; Chen DT; Boney TY; O'Brien CP
Addiction; 2017 Aug; 112(8):1440-1450. PubMed ID: 28239984
[TBL] [Abstract][Full Text] [Related]
3. Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.
Lee JD; Friedmann PD; Boney TY; Hoskinson RA; McDonald R; Gordon M; Fishman M; Chen DT; Bonnie RJ; Kinlock TW; Nunes EV; Cornish JW; O'Brien CP
Contemp Clin Trials; 2015 Mar; 41():110-7. PubMed ID: 25602580
[TBL] [Abstract][Full Text] [Related]
4. Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: a systematic review and meta-analysis.
Bahji A; Carlone D; Altomare J
Addiction; 2020 Aug; 115(8):1413-1425. PubMed ID: 31863669
[TBL] [Abstract][Full Text] [Related]
5. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
Lee JD; Friedmann PD; Kinlock TW; Nunes EV; Boney TY; Hoskinson RA; Wilson D; McDonald R; Rotrosen J; Gourevitch MN; Gordon M; Fishman M; Chen DT; Bonnie RJ; Cornish JW; Murphy SM; O'Brien CP
N Engl J Med; 2016 Mar; 374(13):1232-42. PubMed ID: 27028913
[TBL] [Abstract][Full Text] [Related]
6. Personal Control Over Decisions to Participate in Research by Persons With Histories of Both Substance Use Disorders and Criminal Justice Supervision.
Chen DT; Ko TM; Allen AA; Bonnie RJ; Suratt CE; Appelbaum PS; Nunes EV; Friedmann PD; Lee JD; Gordon MS; McDonald R; Wilson D; Boney TY; Murphy SM; O'Brien CP
J Empir Res Hum Res Ethics; 2018 Apr; 13(2):160-172. PubMed ID: 29460668
[TBL] [Abstract][Full Text] [Related]
7. Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluation.
Adi Y; Juarez-Garcia A; Wang D; Jowett S; Frew E; Day E; Bayliss S; Roberts T; Burls A
Health Technol Assess; 2007 Feb; 11(6):iii-iv, 1-85. PubMed ID: 17280624
[TBL] [Abstract][Full Text] [Related]
8. The SOMATICS collaborative: Introduction to a National Institute on Drug Abuse cooperative study of pharmacotherapy for opioid treatment in criminal justice settings.
Chandler RK; Finger MS; Farabee D; Schwartz RP; Condon T; Dunlap LJ; Zarkin GA; McCollister K; McDonald RD; Laska E; Bennett D; Kelly SM; Hillhouse M; Mitchell SG; O'Grady KE; Lee JD
Contemp Clin Trials; 2016 May; 48():166-72. PubMed ID: 27180088
[TBL] [Abstract][Full Text] [Related]
9. Methadone maintenance treatment may improve completion rates and delay opioid relapse for opioid dependent individuals under community corrections supervision.
Clark CB; Hendricks PS; Lane PS; Trent L; Cropsey KL
Addict Behav; 2014 Dec; 39(12):1736-40. PubMed ID: 25117851
[TBL] [Abstract][Full Text] [Related]
10. Criminal justice continuum for opioid users at risk of overdose.
Brinkley-Rubinstein L; Zaller N; Martino S; Cloud DH; McCauley E; Heise A; Seal D
Addict Behav; 2018 Nov; 86():104-110. PubMed ID: 29544869
[TBL] [Abstract][Full Text] [Related]
11. Extended-release injectable naltrexone for opioid use disorder: a systematic review.
Jarvis BP; Holtyn AF; Subramaniam S; Tompkins DA; Oga EA; Bigelow GE; Silverman K
Addiction; 2018 Jul; 113(7):1188-1209. PubMed ID: 29396985
[TBL] [Abstract][Full Text] [Related]
12. Healthcare utilization in adults with opioid dependence receiving extended release naltrexone compared to treatment as usual.
Soares WE; Wilson D; Rathlev N; Lee JD; Gordon M; Nunes EV; O'Brien CP; Friedmann PD
J Subst Abuse Treat; 2018 Feb; 85():66-69. PubMed ID: 28576389
[TBL] [Abstract][Full Text] [Related]
13. Neurocognitive indicators predict results of an informed-consent quiz among substance-dependent treatment seekers entering a randomized clinical trial.
Kiluk BD; Nich C; Carroll KM
J Stud Alcohol Drugs; 2010 Sep; 71(5):704-12. PubMed ID: 20731975
[TBL] [Abstract][Full Text] [Related]
14. Audio-visual presentation of information for informed consent for participation in clinical trials.
Ryan RE; Prictor MJ; McLaughlin KJ; Hill SJ
Cochrane Database Syst Rev; 2008 Jan; (1):CD003717. PubMed ID: 18254029
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone in the treatment of opioid dependence.
George S; Ekhtiari H
Br J Hosp Med (Lond); 2010 Oct; 71(10):568-70. PubMed ID: 21085073
[No Abstract] [Full Text] [Related]
16. Research on naltrexone in the criminal justice system.
Patapis NS; Nordstrom BR
J Subst Abuse Treat; 2006 Sep; 31(2):113-5. PubMed ID: 16919735
[TBL] [Abstract][Full Text] [Related]
17. Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk.
Brinkley-Rubinstein L; Cloud D; Drucker E; Zaller N
Curr HIV/AIDS Rep; 2018 Jun; 15(3):255-258. PubMed ID: 29752698
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
19. Making consent more informed: preliminary results from a multiple-choice test among probation-referred marijuana users entering a randomized clinical trial.
Rounsaville DB; Hunkele K; Easton CJ; Nich C; Carroll KM
J Am Acad Psychiatry Law; 2008; 36(3):354-9. PubMed ID: 18802184
[TBL] [Abstract][Full Text] [Related]
20. Relapse prevention medications in community treatment for young adults with opioid addiction.
Vo HT; Robbins E; Westwood M; Lezama D; Fishman M
Subst Abus; 2016; 37(3):392-397. PubMed ID: 26820059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
